NAV
31.16(-0.00%)Fund Size (CR)
₹1,339Expense Ratio
2.1Scheme Type
Active FundValue Research
Min. investment
₹5,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹100Minimum Withdrawal
₹500Exit Load
0.25%Return Since Launch
12.50%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Rajat Srivastava
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 11 August 2025 | 10279.41 | 2.79% | - | 1.60% | 71/908 |
1 Month | 18 July 2025 | 10125.21 | 1.25% | - | -0.85% | 149/888 |
3 Month | 16 May 2025 | 10535.24 | 5.35% | - | 2.73% | 151/868 |
6 Month | 18 February 2025 | 11135.78 | 11.36% | - | 12.91% | 538/836 |
1 Year | 16 August 2024 | 10496.02 | 4.96% | 4.96% | 1.29% | 212/721 |
3 Year | 18 August 2022 | 18983.87 | 89.84% | 23.80% | 18.94% | 102/480 |
5 Year | 18 August 2020 | 23848.00 | 138.48% | 18.97% | 22.72% | 297/390 |
Since Inception | 28 December 2015 | 31156.70 | 211.57% | 12.50% | 13.32% | 582/905 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 2 September 2024 | 1,20,000 | 125402.56 | 4.50% | 4.50% |
3 Year | 1 September 2022 | 3,60,000 | 507231.75 | 40.90% | 12.11% |
5 Year | 1 September 2020 | 6,00,000 | 978693.41 | 63.12% | 10.28% |
10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.55%
Standard Deviation
0.94%
Beta
1.11%
Sharpe Ratio
0.03%
Treynor's Ratio
2.36%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
---|---|---|---|---|---|
Sun Pharma.Inds. | 10.92% | 856462 | 146.17 | Equity | Pharmaceuticals |
Cipla | 6.62% | 569903 | 88.60 | Equity | Pharmaceuticals |
Apollo Hospitals | 5.20% | 92826 | 69.60 | Equity | Healthcare |
Lupin | 4.77% | 330887 | 63.83 | Equity | Pharmaceuticals |
Health.Global | 4.38% | 942453 | 58.63 | Equity | Healthcare |
Torrent Pharma. | 4.32% | 154717 | 57.89 | Equity | Pharmaceuticals |
Aster DM Health. | 4.32% | 956991 | 57.89 | Equity | Healthcare |
Fortis Health. | 4.00% | 624597 | 53.56 | Equity | Healthcare |
Alkem Lab | 4.00% | 106435 | 53.55 | Equity | Pharmaceuticals |
Max Healthcare | 3.80% | 407917 | 50.83 | Equity | Healthcare |
Peer Comparison
Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
---|---|---|---|---|---|---|---|
Nippon India Taiwan Equity Fund - Direct (G) | 351.43 | 10.36% | 29.08% | 24.76% | 38.20% | 26.96% | |
Nippon India Taiwan Equity Fund - Direct (IDCW) | 351.43 | 10.36% | 29.08% | 24.76% | 38.20% | 26.96% | |
Aditya Birla SL International Equity Fund - Direct (IDCW) | 229.26 | 5.99% | 13.79% | 16.32% | 30.01% | 14.15% | |
Aditya Birla SL International Equity Fund - Direct (G) | 229.26 | 5.99% | 13.79% | 16.32% | 30.01% | 14.15% | |
DSP Banking & Financial Services Fund - Dir (G) | 1346.44 | -1.15% | 1.43% | 16.30% | 21.55% | - |
List of Schemes under Tata Mutual Fund
News
Tata MF announces change in benchmark index under its scheme
Tata Mutual Fund has announced change in the benchmark of Tata India Pharma and Healthcare Fund with effect from, 07 August 2025Change in name of Benchmark of Tata India Pharma and Healthcare Fund
Scheme Name Existing Benchmark Revised Benchmark Tata India Pharma and Healthcare Fund Nifty Pharma TRI BSE Healthcare TRI Powered by Capital Market - Live News
Tata Mutual Fund announces change in fund manager under its schemes
Tata Mutual Fund has announced change in fund manager under the following schemes, With effect from 01 July 2025Change in Fund Manager:
Name of the Scheme(s) Existing Fund Manager(s) New Fund Manager(s) Tata Housing Opportunities Fund 1. Tejas Gutka
2. Hasmukh Vishariya #
3. Murthy Nagarajan1. Aditya Bagul
2. Kapil Malhotra *
3. Hasmukh Vishariya #
4. Murthy NagarajanTata ELSS Fund 1. Tejas Gutka
2. Sailesh Jain *1. Rahul Singh
2. Sailesh Jain *Tata India Pharma and Healthcare Fund 1. Meeta Shetty
2. Rajat SrivastavaRajat Srivastava Tata Large & Midcap Fund 1. Chandraprakash Padiyar
2. Meeta Shetty *1. Chandraprakash Padiyar
2. Kapil Malhotra *Tata Nifty 50 Exchange Traded Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata Nifty 50 Index Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata Nifty India Digital ETF Fund of Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata Nifty India Digital Exchange Traded Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata Nifty Midcap 150 Momentum 50 Index Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata BSE Sensex Index Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata Gold Exchange Traded Fund 1. Tapan Patel ^
2. Kapil Menon1. Tapan Patel ^
2. Nitin SharmaTata Silver Exchange Traded Fund 1. Tapan Patel ^
2. Kapil Menon1. Tapan Patel ^
2. Nitin SharmaTata Nifty Realty Index Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata Nifty Auto Index Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata Nifty Financial Services Index Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata Nifty MidSmall Healthcare Index Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata Nifty 500 Multicap India Manufacturing 50:30:20 Index Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata Nifty500 Multicap Infrastructure 50:30:20 Index Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata Nifty India Tourism Index Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata Nifty 200 Alpha 30 Index Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata Nifty Capital Markets Index Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata BSE Select Business Groups Index Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata BSE Quality Index Fund Kapil Menon 1. Nitin Sharma
2. Rakesh Prajapati *Tata Nifty Midcap 150 Index Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Tata Nifty Private Bank Exchange Traded Fund 1. Kapil Menon
2. Rakesh Prajapati *1. Nitin Sharma
2. Rakesh Prajapati *Powered by Capital Market - Live News
Tata MF announces Income Distribution cum capital withdrawal (IDCW) under two schemes
Tata Mutual Fund has announced 02 July 2025 as the record date for declaration of Income Distribution cum capital withdrawal (IDCW) under the monthly IDCW option and under the Periodic IDCW Periodic-Payout/Reinvestment) of following schemes. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:Tata Hybrid Equity Fund ' Regular Plan & Direct Plan: 0.36 each.
Tata Equity Savings Fund ' Regular Plan & Direct Plan: 0.059 each.
Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
4 December 2015
Total AUM (Cr)
₹1339.00
Tata India Pharma & Healthcare Fund (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, Tata Mutual Fund. Launched in 4 December 2015, this fund is managed by Rajat Srivastava. With assets under management (AUM) worth ₹1,339 (Cr), as of 19 August 2025, Tata India Pharma & Healthcare Fund (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 12.50% since its launch.
The current NAV of Tata India Pharma & Healthcare Fund (G) is ₹31.16, as on 19 August 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in Tata India Pharma & Healthcare Fund (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹100 while the minimum lumpsum investment is ₹5,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment. The fund has generated 23.80% and 18.97% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 93.81% in Equity, 4.56% in Debt and 1.63% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 55.03% in Pharmaceuticals & Biotech, 35.30% in Healthcare Services, 4.56% in Debt, 2.60% in Insurance, 1.63% in Cash & Others